Download Journal Club 12-13 Article Presenters

Journal Club 12-13
Article
Jul 17 ‘12
Anemia After Kidney Transplantation; Its Prevalence,Risk Factors, and Independent Association
With Graft and Patient Survival: A Time-Varying Analysis. Transplantation – Vo. XX, Number
XX Month XX, 2012
Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD
J Am Soc Nephrol 22: 2313–2321, 2011
Presenters
Ahmed
Vandevar
Aug 21 ‘12
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation; N Engl J Med
2012;367:329-39. DOI: 10.1056/NEJMoa1204166
Jasani
Sep 18 ‘12
Bone and Mineral Metabolism and Fibroblast Growth Factor 23 Levels After Kidney Donation
Am J Kidney Dis. 2012;59(6):761-769
Borgella
Oct 16 ‘12
Effects of High-Dose Erythropoietin on Graft Function after Kidney Transplantation. Clin J Am
Soc Nephrol 7:1498-1506, 2012.
Jasani
Oct 30 ‘12
Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for
Prevention of Cytomegalovirus in Renal Transplantation J Am Soc Nephrol 23(9):1588-97, 2012
Vandevar
Nov 20 ‘12
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis. N Engl J Med
2012 DOI: 10.1056/NEJMoa1205624
Hames
Dec 18 ‘12
Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome.
N Engl J Med 2012;367:2296-304.
Jasani
Jan 15 ‘13
Jan 29 ‘13
Feb 19 ‘13
Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic
Lymphangioleimyomatosis: A Phase 2 Trail Clin Cancer Res 2011;17:4071-4081. Published
OnlineFirst April 27, 2011.
Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration
Strategy and Kidney Injury in Critically Ill Adults. JAMA 2012;308(15):1566-1572
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease.
N Engl j Med 367;25 nejm.org december 20, 2012 N Engl J Med 2012;367:2407-18.
DOI: 10.1056/NEJMoa1205511
Ahmed
Borgella
Vandevar
Mar 19 ‘13
Presence of Urinary Haufen Accurately Predicts Polyomavinus Nephropathy
J Am Soc Nephrol 20: 416–427, 2009. doi: 10.1681/ASN.2008010117
Borgella
Apr 16 ‘13
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Engl J Med 2012;367:2204-13. DOI:10.1056/NEJMoa1208799
DOI: 10.1056/NEJMoa1208799
Desai
Apr 30 ‘13
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its
anticancer efficiency in rats
Kidney International (2012) 82, 652–663; doi:10.1038/ki.2012.199;
Ahmed
May 21 ‘13
Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients
Previously Treated with Darbepoetin Alfa
Jun 18 ‘13
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD. Clin J
Am Soc Nephrol ePress, published 3/7/13 as doi: 10.2215/CJN.09250912
6/6/13 eb
Clin J Am Soc Nephrol 8: 538–545, 2013. doi: 10.2215/CJN.03440412
Vandevar
Hames